Pharmafile Logo
Pharmafocus logo
Advanced Search

Full year revenue and EBITDA in line with guidance Remain focused on post-COVID-19 growth strategy to become a leading global clinical diagnostics company in infectious diseases

January 26, 2023
Business Services

Paris, France and Eastleigh, UK – 26 January 2023 – Novacyt (EURONEXT GROWTH: ALNOV; AIM: NCYT), an international specialist in …

News
Press release

Brits Living with Diabetes Feel Stigma and Bias Impact Their Ability to Manage Their Condition

January 26, 2023
Business Services

MAIDENHEAD, BERKSHIRE – TUESDAY 24 JANUARY 2023 – With diabetes prevalence expected to reach almost 5.5 million across the UK …

News
Press release

US Center for Disease Control (CDC) and two major medical journals cite the importance of decolonization in preventing surgical site infections

January 25, 2023
Business Services

Brighton, United Kingdom – 25 January 2023 – Destiny Pharma plc (AIM: DEST), a clinical stage biotechnology company focused on …

News
Press release

Vertex and CRISPR Therapeutics Announce EMA Marketing Authorization Application Validation for CRISPR/Cas9 GeneEdited Therapy, exagamglogene autotemcel (exa

January 25, 2023
Business Services

LONDON, UK and ZUG, Switzerland, January 25, 2023 – Vertex Pharmaceuticals (Europe) and CRISPR Therapeutics (Nasdaq: CRSP) today announced that …

News
Press release

STORM Therapeutics Presents STC-15 Preclinical Data Supporting Treatment of Patients with AML at the AACR Acute Myeloid Leukemia and Myelodysplastic Syndrome Conference

January 25, 2023
Business Services

25 January 2023, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule …

News
Press release

Scancell Holdings plc: Interim Results for the 6 months ended 31 October 2022

January 25, 2023
Business Services

Scancell Holdings plc (AIM: SCLP), the developer of novel immunotherapies for the treatment of cancer and infectious disease, today announces …

News
Press release

Sosei Heptares Webinar Presentation for FY2022 Financial Results

January 25, 2023
Business Services

Tokyo, Japan and Cambridge, UK, 25 January 2023 – Sosei Group Corporation (“the Company”; TSE: 4565), the world leader in …

News
Press release

Bristol Myers Squibb sues AstraZeneca over alleged patent infringement of cancer drug

January 25, 2023
Medical Communications

Bristol Myers Squibb (BMS) has filed a lawsuit against AstraZeneca, alleging that AstraZeneca’s Imjudo infringes patents from its blockbuster drug …

News

Eli Lilly plans to invest $450m at production site in Research Triangle Park

January 25, 2023
Manufacturing and Production

US-based pharmaceutical company, Eli Lilly and Company, has announced plans to invest $450m in its manufacturing facilities at Research Triangle …

News

Poxel given EC’s Orphan Drug Designation for rare metabolic disorders

January 25, 2023
Research and Development

Clinical stage biopharmaceutical company Poxel, who focus on developing innovative treatments for chronic, serious diseases with metabolic pathophysiology, has been …

News

Thermo Fisher Scientific announces launch of CE-IVD marked assay to detect treatment-resistant strains of HIV-1

January 25, 2023
Medical Communications

US-based Thermo Fisher Scientific has announced the launch of its CE-IVD marked Applied Biosystems Taqpath Seq HIV-1 Genotyping kit. It …

News

finnCap Cavendish advises on the sale of Therapy Equipment Limited to ESAB Corporation

January 24, 2023
Business Services

London, 24th January – finnCap Cavendish, part of finnCap Group plc, is pleased to announce it has advised on the …

News
Press release

UK seeing exodus of R&D activity, research reveals

January 24, 2023
Business Services

London, 24 January 2023: The UK is experiencing a crisis where firms are moving R&D activity abroad, according to research …

News
Press release

Amber Therapeutics announces successful first-in-human implants of Amber-UI: an intelligent, closed-loop bioelectrical therapy for urge and mixed urinary incontinence

January 24, 2023
Business Services

London, UK and Antwerp, Belgium. 24th January 2023 – Amber Therapeutics (‘Amber’ or the ‘Company’), a University of Oxford spinout …

News
Press release

2022 Novo Holdings Seed Investments team Review/Business Update

January 24, 2023
Business Services

Copenhagen, Denmark, 24 January 2023 – Seed Investments, the early stage investment and company creation team of Novo Holdings, today …

News
Press release

Global Company Foot Science International Choose Onyx Health

January 24, 2023
Business Services

Leading orthotics company Foot Science International has joined forces with creative agency Onyx Health to launch a new medical education …

News
Press release

Neuraxpharm completes its presence in Benelux by opening an affiliate in Brussels to cover Belgium and Luxembourg

January 24, 2023
Business Services

Brussels and Düsseldorf – January 24, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the …

News
Press release

Europe plans further antibiotic shortage countermeasures

January 24, 2023
Medical Communications

With respiratory infections increasing, an ongoing cost of living crisis and the Russia-Ukraine conflict, officials throughout Europe are beginning to …

News

WHO issues a “call to action” after cough syrup deaths

January 24, 2023
Medical Communications

WHO has released an urgent “call to action” to all 194 WHO member states in order to try and prevent, …

News

TheracosBio’s oral drug approved by FDA for adults with type 2 diabetes

January 24, 2023
Research and Development

TheracosBio has announced that the first oral SGLT2 inhibitor, bexaflilozin, has been approved by the FDA for the treatment of …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026